BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18096213)

  • 41. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
    Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
    Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat.
    Naderi N; Ahmad-Molaei L; Aziz Ahari F; Motamedi F
    Neurochem Res; 2011 Aug; 36(8):1520-5. PubMed ID: 21516342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
    Nawata Y; Yamaguchi T; Fukumori R; Yamamoto T
    Int J Neuropsychopharmacol; 2019 Feb; 22(2):165-172. PubMed ID: 30481332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
    Hansson AC; Bermúdez-Silva FJ; Malinen H; Hyytiä P; Sanchez-Vera I; Rimondini R; Rodriguez de Fonseca F; Kunos G; Sommer WH; Heilig M
    Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.
    Umathe SN; Manna SS; Jain NS
    Behav Brain Res; 2011 Sep; 223(1):125-34. PubMed ID: 21549765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.
    Solinas M; Panlilio LV; Tanda G; Makriyannis A; Matthews SA; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2046-57. PubMed ID: 15870833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
    Haller J; Barna I; Barsvari B; Gyimesi Pelczer K; Yasar S; Panlilio LV; Goldberg S
    Psychopharmacology (Berl); 2009 Jul; 204(4):607-16. PubMed ID: 19259645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
    Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
    Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
    Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
    Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model.
    Adamson Barnes NS; Mitchell VA; Kazantzis NP; Vaughan CW
    Br J Pharmacol; 2016 Jan; 173(1):77-87. PubMed ID: 26398331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Naidu PS; Varvel SA; Ahn K; Cravatt BF; Martin BR; Lichtman AH
    Psychopharmacology (Berl); 2007 May; 192(1):61-70. PubMed ID: 17279376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.
    Batista LA; Bastos JR; Moreira FA
    J Psychopharmacol; 2015 Mar; 29(3):335-43. PubMed ID: 25601395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.
    Bambico FR; Duranti A; Nobrega JN; Gobbi G
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):578-90. PubMed ID: 26747370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats.
    Roche M; Kelly JP; O'Driscoll M; Finn DP
    Immunology; 2008 Oct; 125(2):263-71. PubMed ID: 18393970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.
    Rubino T; Realini N; Castiglioni C; Guidali C; Viganó D; Marras E; Petrosino S; Perletti G; Maccarrone M; Di Marzo V; Parolaro D
    Cereb Cortex; 2008 Jun; 18(6):1292-301. PubMed ID: 17921459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C; Markert A; Zimmer A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC
    Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
    Araya KA; David Pessoa Mahana C; González LG
    Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.